PDLIM7 and carcinoma: We found that hypermutation was detected in 4 out of 6 LMP1(+), and 5 out of 12 LMP1(‐) cases (Figure S6D) In addition, it was found in 9 out of 14 cases histologically diagnosed with type II carcinoma (non‐keratinizing), but none of 4 cases with type III carcinoma (undifferentiated).